Seller record · Telehealth service

Eden

By Peptide Alliance, Editorial publisherRecorded August 2026 · Standard v1.1 · How checks are performed

Fails 1 of 8 criteria. S5, analytical documentation: No certificate, lot report or test document appears on the treatment pages, the safety page, or anywhere else on the site.

At a glance

EdenTelehealth service

7/8criteria passed

Price: Semaglutide $99 a month plus membership
Sells: compounded semaglutide, compounded tirzepatide, brand Zepbound, and 5 more
FDA letters: 1 on file

Partner link. The site earns a commission on care started through it. Funding

Visit Eden See all eight dispositions

Telehealth service. Passes 7 of 8 criteria. Recorded against Standard v1.1.

One company behind three domains, with the storefront domain redirecting into another. It names four partner pharmacies with street addresses.

Operating entity Eden Health International Inc. The brand sells from 3 storefronts of its own, recorded here as one entry: Eden's website, and 2 other domains of its own.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Eden's terms of service page; Eden's website
S2	Prescription gating	PASS	Eden's weight loss page on its app site
S3	Pharmacy identification	PASS	Eden's about page
S4	Compounding disclosure	PASS	Eden's website
S5	Analytical documentation	FAIL	Eden's sitemap page
S6	Business address	PASS	Eden's get help page
S7	Price disclosure	PASS	Eden's GLP-1 treatments product page
S8	Enforcement status	PASS	FDA's website; FDA warning letter 728279

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSEnrollment is contingent on evaluation by a licensed provider, and prescriptions issue only after an online consultation with an independent licensed provider.Source: Eden's terms of service page; Eden's website.

S2PASSThe first intake question, which asks the reasons for seeking treatment, stops the order.Source: Eden's weight loss page on its app site.

S3PASSFour partner pharmacies are named with street addresses: GoGoMeds, Precision, Enovex and AbsolutePharmacy.Source: Eden's about page.

S4PASSCompounded medications are not approved by the FDA and have not been reviewed for safety, effectiveness, or quality, printed on the home page.Source: Eden's website.

S5FAILNo certificate, lot report or test document appears on the treatment pages, the safety page, or anywhere else on the site.Source: Eden's sitemap page.

S6PASS110 16th St, Ste 1431, Denver, CO 80202 on the help page, matching the address on the warning letter; the terms give a Wilmington registered agent instead.Source: Eden's get help page.

S7PASSCompounded semaglutide is printed at 99 dollars per month for medication only, with membership at 39 dollars for the first month and 99 dollars per month afterward.Source: Eden's GLP-1 treatments product page.

S8PASSFDA warning letter 728279, June 2026, names Eden Health International Inc. doing business as Eden at 110 16th St Ste 1431, Denver, Colorado, the address its own help page prints. It alleges that the pictured labels suggest Eden is the compounder when it is not, and that the site claimed its products come from FDA-licensed 503(a) outsourcing facilities. No close-out letter appears in the index. No FDA action has halted the business, and the seller still trades.Source: FDA's website; FDA warning letter 728279.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, brand Zepbound, brand Wegovy, brand Mounjaro, sermorelin, NAD+, hair growth kits.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+

Enforcement documents on file: 1 warning letter

FDA warning letter 728279, issued June 2026, to Eden Health International Inc. dba EdenPictured labels identify Eden as the compounder when it is not, and the site described its sources as FDA-licensed 503(a) outsourcing facilities, a designation FDA does not grant.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Partner link. The site earns a commission on care started through it. Funding.

Visit Eden

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.